What neuropsychiatric manifestations can isoniazid cause and how should they be managed?

Isoniazid-Induced Neuropsychiatric Manifestations

Isoniazid causes peripheral neuropathy, seizures, and psychotic symptoms (delusions, hallucinations, mania) as its primary neuropsychiatric manifestations, with peripheral neuropathy being the most common and dose-related. 1, 2

Primary Neuropsychiatric Manifestations

Peripheral Neuropathy

• Most common neurotoxic effect and is dose-related 2
• Typically preceded by paresthesias of the feet and hands
• Higher incidence in:
  • Malnourished patients
  • Diabetics
  • Alcoholics
  • Uremic patients
  • "Slow acetylators" 3

Psychotic Symptoms

• Delusions and/or hallucinations are the most common presentations 1, 4
• Typically occurs within the first 2 months of treatment, with earlier onset in patients ≤18 years 4
• Additional manifestations include:
  • Psychomotor disturbances
  • Disorganized speech or formal thought disorder
  • Disorganized or abnormal behavior
  • Mania 5
  • Visual hallucinations (including bright colors and strange designs) 2

Seizures

• Part of acute overdose syndrome but can occur at therapeutic doses
• Appear within 30 minutes to 3 hours after toxic ingestion 2
• Associated with severe metabolic acidosis 2, 6

Other Neuropsychiatric Effects

• Toxic encephalopathy
• Optic neuritis and atrophy
• Memory impairment
• Toxic psychosis
• Sleep disturbances
• Hostility or aggression
• Confusion 1, 2

Management Algorithm

For Peripheral Neuropathy

Step 1: Prevention (Primary Strategy)

• Pyridoxine 50 mg daily prophylactically for all high-risk patients 3:
  • Diabetes
  • Uremia
  • Alcoholism
  • Malnutrition
  • Pregnant women
  • Seizure disorder patients
  • HIV-infected patients
  • Advanced age
  • Chronic renal failure 7

Step 2: Treatment of Mild Neuropathy

• Increase pyridoxine dose to 100 mg daily 1, 7
• Reduce isoniazid dose if symptoms persist 1

Step 3: Treatment of Severe or Persistent Neuropathy

• Stop isoniazid immediately if severe or not responding to increased pyridoxine 1

For Neuropsychiatric Effects (Psychosis, Mania, Behavioral Changes)

Step 1: Verify Correct Dosing

• Confirm patient is receiving correct dose, as overdosing is associated with adverse events 1

Step 2: Dose Reduction

• Reduce isoniazid dosage and monitor clinical effect 1

Step 3: Drug Discontinuation

• If no improvement with dose reduction, stop isoniazid 1
• Symptoms typically resolve after discontinuation 8, 5

Step 4: Rechallenge Consideration

• Avoid rechallenge: >80% of cases rechallenged with isoniazid resulted in recurrence of psychotic symptoms 4
• If rechallenge is attempted (only when no alternative exists), reintroduce at lower dose with close monitoring 1

For Acute Overdose with Seizures

Immediate Management:

1. Administer pyridoxine IV on a gram-for-gram basis equal to isoniazid dose 2, 6

   • If dose unknown: 5 grams IV in adults over 30-60 minutes 2
   • If dose unknown: 80 mg/kg IV in children 2, 6
   • Give over 3-5 minutes as slow IV bolus for symptomatic patients 2

2. Add benzodiazepines (diazepam) for synergistic seizure control 2, 6

3. Repeat pyridoxine if seizures continue (rarely need >10 grams total) 2

4. Avoid phenytoin as isoniazid interferes with its metabolism 3, 2

5. Ensure adequate ventilation and support cardiac output 2

6. Administer activated charcoal if patient presents early and airway can be protected 2

Critical Pitfalls to Avoid

1. Do not use the pediatric "70 mg/kg" pyridoxine recommendation for overdose - this is inadequate and based on unclear rationale. Use gram-for-gram dosing regardless of age 6

2. Do not assume pyridoxine supplementation prevents psychosis - while effective for peripheral neuropathy, its role in preventing psychotic symptoms is unclear 4, 9

3. Do not miss early psychotic symptoms - assess patients specifically for delusions, hallucinations, and behavioral changes, especially in the first 2 months of therapy 4

4. Do not rechallenge with isoniazid after psychotic episode unless absolutely no alternative exists, as recurrence rate exceeds 80% 4

5. Do not delay pyridoxine administration in overdose - waiting for laboratory confirmation wastes critical time when seizures are imminent or occurring 2, 6

Monitoring Recommendations

• Evaluate patients monthly during therapy for neuropsychiatric symptoms 3
• Heightened surveillance in first 2 months when psychotic symptoms most commonly emerge 4
• Train directly observed therapy workers to identify neuropsychiatric symptoms 3
• Monitor phenytoin levels if co-administered, as isoniazid increases serum concentrations of both drugs 3